Agnieszka Marcinowicz-Flick

Title: Agnieszka Marcinowicz-Flick: Innovator in IDO Inhibitors

Introduction

Agnieszka Marcinowicz-Flick is a prominent inventor based in Ames, IA (US). She has made significant contributions to the field of immunology through her innovative work on indoleamine 2,3-dioxygenase (IDO) inhibitors. Her research focuses on developing methods to modulate IDO activity, which plays a crucial role in immunosuppression and cancer treatment.

Latest Patents

Agnieszka holds 1 patent related to IDO inhibitors. The patent outlines various methods for modulating IDO activity, including treating IDO-mediated immunosuppression, enhancing the effectiveness of anti-cancer treatments, and addressing immunosuppression associated with infectious diseases such as HIV-I. These methods involve administering effective amounts of specific compounds to achieve desired therapeutic outcomes.

Career Highlights

Agnieszka is currently associated with Newlink Genetics Corporation, where she continues her research and development efforts. Her work has the potential to impact cancer therapies and improve patient outcomes significantly.

Collaborations

Agnieszka collaborates with notable colleagues, including Mario Mautino and Firoz Jaipuri, to advance her research initiatives and explore new therapeutic avenues.

Conclusion

Agnieszka Marcinowicz-Flick is a dedicated inventor whose work on IDO inhibitors is paving the way for innovative treatments in immunology and oncology. Her contributions are vital in the ongoing fight against cancer and infectious diseases.